Raltegravir in second-line ART in resource-limited settings

Affiliations

¹ Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland.
² Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland. Electronic address: olivia.keiser@ispm.unibe.ch.

Free article

Comment

Andreas D Haas et al. Lancet HIV. 2016 Jun.

Free article

. 2016 Jun;3(6):e240-1.

doi: 10.1016/S2352-3018(16)30014-5. Epub 2016 Apr 18.

¹ Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland.
² Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland. Electronic address: olivia.keiser@ispm.unibe.ch.

No abstract available

Comment on

Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study.
La Rosa AM, Harrison LJ, Taiwo B, Wallis CL, Zheng L, Kim P, Kumarasamy N, Hosseinipour MC, Jarocki B, Mellors JW, Collier AC; ACTG A5273 Study Group. La Rosa AM, et al. Lancet HIV. 2016 Jun;3(6):e247-58. doi: 10.1016/S2352-3018(16)30011-X. Epub 2016 Apr 18. Lancet HIV. 2016. PMID: 27240787 Free PMC article. Clinical Trial.